Merck Performance Details
Yesterday, I reported that I sold my position in Merck (MRK) in the Fat Pitch Financials Portfolio. I have some additional performance statistics to provide on this trade.
According to Marketocracy, I had a total return of 76.89% on the 5,000 shares of Merck purchased on October 4, 2004. The appreciation in share price alone was 63.19%. The year-to-date return on Merck price was 31.03%.
Here is a look of the cash flows associated with my Merck position in my portfolio:
| Date | Amount |
|
10/4/2004 |
($171,445.80) |
|
1/3/2005 |
$1,900.00 |
|
4/1/2005 |
$1,900.00 |
|
7/1/2005 |
$1,900.00 |
|
10/3/2005 |
$1,900.00 |
|
1/3/2006 |
$1,900.00 |
|
4/3/2006 |
$1,900.00 |
|
7/3/2006 |
$1,900.00 |
|
10/2/2006 |
$1,900.00 |
|
1/2/2007 |
$1,900.00 |
|
4/2/2007 |
$1,900.00 |
|
7/2/2007 |
$1,900.00 |
|
10/1/2007 |
$1,900.00 |
|
11/6/2007 |
$279,780.00 |
|
IRR |
21.2% |
Each of those $1,900 payments came from the $0.38 quarterly dividends issued by Merck. I used Excel’s XIRR function to determine that my annualized rate of return on my Merck position was a solid 21.2%. I’m very happy with that return and look forward to finding another fat pitch opportunity to replace Merck in my portfolio. Any ideas?
Ahh, Too bad you didn’t hold on to MRK for a few more days